trending Market Intelligence /marketintelligence/en/news-insights/trending/b_CPir8CH9LR2aPv-6argA2 content esgSubNav
In This List

Catalyst Biosciences prices common stock offering

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Catalyst Biosciences prices common stock offering

Catalyst Biosciences Inc. priced an underwritten public offering of 1,105,263 common shares at $9.50 apiece for expected gross proceeds of about $10.5 million.

The offering is expected to close Dec. 22.

JonesTrading Institutional Services LLC and Ladenburg Thalmann & Co. Inc. are acting as joint book-running managers. LifeSci Capital LLC is acting as a co-manager for the proposed offering.